Ozempic® (Semaglutide Injection) and Saxenda® (Liraglutide Injection): These are injectable medications that work as GLP-1 receptor agonists to reduce appetite and promote feelings of fullness. They do not provide the essential nutrients, vitamins, minerals, or calories required for a balanced diet. These medications are intended to help control hunger and support weight loss as part of a comprehensive weight management plan that includes a healthy diet.

Orlistat: This oral medication works by blocking the absorption of dietary fats in the gastrointestinal tract, thereby reducing calorie intake from fats. Orlistat does not contain any nutrients and should be used alongside a balanced, low-fat diet rather than as a substitute for food.

RYBELSUS® (Oral Semaglutide): Like the injectable GLP-1 receptor agonists, RYBELSUS® is an oral medication that reduces appetite and helps with weight management but does not provide any caloric or nutritional value.

Weight Management vs. Nutrition: GoSlim products are intended to aid in weight loss and manage weight-related conditions such as obesity and type 2 diabetes by affecting appetite, metabolism, and fat absorption. Meal replacements, on the other hand, are designed to provide a balanced mix of macronutrients (proteins, carbohydrates, fats) and micronutrients (vitamins and minerals) to substitute for a meal. Using GoSlim products as meal replacements would not meet the body’s nutritional needs and could lead to malnutrition or other health issues.

Medical Supervision: GoSlim products should be used under the guidance of a healthcare professional, particularly because they affect physiological processes like appetite regulation and fat absorption. They are part of a broader weight management strategy that includes dietary changes and increased physical activity. Meal replacements, in contrast, are typically used to substitute specific meals and are often regulated differently to ensure they provide complete nutrition.